Overview Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of ONO-5334 in postmenopausal women with osteopenia or osteoporosis. Phase: Phase 2 Details Lead Sponsor: Ono Pharma USA Inc